| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 2026-05-05 | 2,887 | $206.77 | $596.94kSell |
| Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 2026-05-05 | 1,697 | $206.77 | $350.89kSell |
| Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 2026-05-05 | 1,454 | $241.39 | $350.98kSell |
| Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 2026-05-05 | 948 | $205.22 | $194.55kSell |
| Matthew Rabinowitz | EXECUTIVE CHAIRMAN | 2026-05-04 | 722 | $206.16 | $148.85kSell |
| Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | 2026-05-04 | 482 | $210.49 | $101.46kSell |
| John Fesko | PRESIDENT CHIEF BUS. OFFICER | 2026-05-01 | 291 | $206.16 | $59.99kSell |
| Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2026-05-01 | 865 | $204.47 | $176.86kSell |
| Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2026-05-01 | 400 | $205.31 | $82.12kSell |
| Solomon Moshkevich | PRESIDENT CLINICALDIAGNOSTICS | 2026-05-01 | 150 | $206.93 | $31.04kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Jpmorgan Chase Co | 8.98% | 12,854,334 | $2.50B | Institution |
| Vanguard Group Inc | 8.59% | 12,306,424 | $2.39B | Institution |
| Price T Rowe Associates Inc | 7.59% | 10,871,989 | $2.11B | Institution |
| Blackrock Inc | 7.58% | 10,859,441 | $2.11B | Institution |
| Claremont Creek Ventures L P | 4.09% | 5,864,630 | $1.14B | Insider |
| Roelof Botha | 3.92% | 5,609,535 | $1.09B | Insider |
| Sc XII Management LLC | 3.79% | 5,421,122 | $1.05B | Insider |
| Wellington Management Group LLP | 3.47% | 4,976,325 | $966.60M | Institution |
| Matthew Rabinowitz | 3.43% | 4,906,411 | $953.02M | Insider |
| James Healy | 3.28% | 4,697,100 | $912.36M | Insider |